More about

Lipoprotein

News
February 16, 2023
9 min read
Save

The potential next pathway to target in CVD prevention: ‘Common’ elevated Lp(a)

The potential next pathway to target in CVD prevention: ‘Common’ elevated Lp(a)

About 20% of the global population and one in five U.S. adults have elevated levels of lipoprotein(a), a complex form of LDL that strongly predicts risk for coronary disease and aortic valve stenosis.

News
December 14, 2022
2 min read
Save

High Lp(a) in childhood linked to adult ASCVD risk

High Lp(a) in childhood linked to adult ASCVD risk

High lipoprotein(a) measured during childhood was predictive of atherosclerotic CVD development during adulthood, according to an analysis of two cohorts published in Circulation.

News
November 16, 2022
3 min watch
Save

VIDEO: Takeaways from AHA 2022 with Dipti Itchhaporia, MD, FACC, FESC

VIDEO: Takeaways from AHA 2022 with Dipti Itchhaporia, MD, FACC, FESC

CHICAGO — In this Healio video exclusive, Dipti Itchhaporia, MD, FACC, FESC, discusses some of the late-breaking science presented at the American Heart Association Scientific Sessions.

News
November 14, 2022
3 min read
Save

In FH, Lp(a) levels comparable to LDL in risk for premature poor outcomes

In FH, Lp(a) levels comparable to LDL in risk for premature poor outcomes

Lipoprotein(a) levels of 67 mg/dL or more may be indicative of similar risk for premature MI as LDL of 180 mg/dL or more in patients with familial hypercholesterolemia, researchers reported.

News
October 21, 2022
3 min read
Save

Lp(a) ‘should be measured at least once’ in adults to target CV risk

Lp(a) ‘should be measured at least once’ in adults to target CV risk

BOSTON — There is strong evidence for a casual association between lipoprotein(a) concentration and CV outcomes across ethnicities, and Lp(a) “should be measured at least once” in all adults to identify high CV risk, according to a speaker.

News
October 03, 2022
1 min read
Save

Top in cardiology: Benefits of aspirin in patient subgroup; fish oil supplement risks

Top in cardiology: Benefits of aspirin in patient subgroup; fish oil supplement risks

Older adults with elevated lipoprotein(a)-associated genotypes may benefit from low-dose aspirin for primary prevention of cardiovascular events, according to researchers.

News
September 26, 2022
3 min read
Save

Aspirin ‘benefit may outweigh harm’ in some elevated Lp(a) genotypes

Aspirin ‘benefit may outweigh harm’ in some elevated Lp(a) genotypes

Low-dose aspirin for primary prevention of CV events may benefit older adults with elevated lipoprotein(a)-associated genotypes, according to a new analysis of the ASPREE trial.

News
September 09, 2022
3 min read
Save

Obicetrapib decreases LDL, increases HDL in phase 2 trial

Obicetrapib decreases LDL, increases HDL in phase 2 trial

In a phase 2 trial, obicetrapib, an investigational cholesteryl ester transfer protein inhibitor, decreased LDL, non-HDL, lipoprotein(a) and apolipoprotein B and increased HDL at 8 weeks, researchers reported in Nature Medicine.

News
August 18, 2022
1 min read
Save

High Lp(a) levels ‘strongly associated’ with aortic dissection

High Lp(a) levels ‘strongly associated’ with aortic dissection

Data from a retrospective study suggest adults with very high levels of lipoprotein(a) are eight times more likely to experience aortic dissection compared with those with lower levels, independent of other CV risk factors.

News
August 08, 2022
3 min read
Save

No dementia, cognitive risk with PCSK9 inhibition; statin findings mixed

No dementia, cognitive risk with PCSK9 inhibition; statin findings mixed

Data from a genetics-based study show PCSK9 inhibition does not affect cognition function or dementia risk; however, statin use may be associated with some impaired cognitive performance that is outweighed by any CV benefits.

View more